Poly(ADP-ribose)polymerase-l Enzyme activity Poly(ADP-ribosyl)ation is a posttranslational modification, which is involved in many cellular functions, including DNA repair and maintenance of genomic stability, and has also been implicated in cellular and organismal ageing, We have previously reported that maximum poly(ADP-ribosyl)ation capacity in mononuclear blood cells is correlated with mammalian life span. Here we show that the difference between a long-lived and a short-lived species tested (i,e. man and rat) is directly mirrored by the enzymatic parameters of recombinant poly(ADP-ribose) polymerase-1 (PARP-1), Le, substrate affinity and reaction velocity. In addition, we have characterized two human PARP-1 alleles and assign their activity difference to their respective initial velocity and not substrate affinity.
Evolutionary theory predicts that the ageing process results from accumulation of somatic damage, owing to limited investments in maintenance and repair (I<irkwood, 2008) . Genes controlling the activities of protective systems, such as DNA repair and antioxidant defence, should thus regulate longevity. Recent experimental work in mouse models with various deficiencies in DNA repair functions has yielded strong evidence in support of this view (Hoeijmakers, 2009) .
We have focused on one biochemical reaction contributing to the DNA base-excision repair pathway, i.e. poly(ADP-ribosyl)ation, a posttranslational modification of proteins, Poly(ADP-ribosyl)ation is catalyzed by the family of poly(ADP-ribose) polymerases (PARPs), using NAD+ as substrate. The reaction can be dissected in three distinct steps: initiation (transfer of the first ADP-ribosyl residue), elongation (attachment of further ADP-ribosyl residues), and branching. PARPs have been implicated in many aspects of cellular mechanisms like DNA repair (Blirkle, 2006) , replication (Simbulan-Rosenthal et aI., 1996 , 1998 , mitosis (Canudas et aI., 2007; Chang et aI., 2005) , telomere maintenance (Beneke et aI., 2008; Smith et aI., 1998) , chromatin organization (Gottschalk et aI., 2009; Poirier ct aI., 1982; Timinszky et aI., 2009) , and transcription (Hassa and Hottiger, 1999; Meisterernst et al.. 1997; Oei et aI., 1997) . Likewise, regulation of cell death pathways is mediated by PARPs and their product, poly(ADP-ribose) (PAR). Physiological levels of PAR are highly increased by activation of mainly PARP-1 by the presence of DNA strand breaks. Over-activation of PARP-1 can lead to irreversible depletion of energy-rich metabolites (NAD+/ATP) and subsequently, cell death can occur due to energy failure (necrosis) (Berger et aI., 1983) or release of AIF from mitochondria, initiating caspase-independent apoptosis (/(oh et aI., 2005) . PARP-1 and its activity is also involved in cellular ageing, either in complex with interaction partners (von Kobbe et al .. 2004) or by its ability to regulate cell death (Beneke and Bi.irkle, 2007) . Poly(ADP-ribose) formation capacity decreases with age in humans and rats (Grube and Blirl<le, 1992) but interestingly, centenarian-derived cells display higher poly(ADP-ribosyl)ation capacity than controls (Muiras et al., 1998) . Furthermore, fully stimulated PARP activity in permeabilized mononuclear blood cells (PBMC) of mammalian species is directly correlated with species-specific life span (Grube and Bi.irkle, 1992) , with as-fold difference between the longest lived and shortest lived species tested, Le" rat and man, This correlation is in line with the role of DNA repair factors playing an important role in longevity assurance (Kirkwood, 2008; Hoeijmakers, 2009 ). The correlation, however, was not due to differences in PARP-1 protein levels. Instead we could show that the enzyme of a long-lived species (man) was intrinsically more active that that of a short-lived species (rat) (Beneke et aI., 2000) , which could in part explain the above mentioned differences in cellular poly(ADP-ribosyl)ation capacity. Recently, allelic substitution of the more common valine First publ. in: Mechanisms of Ageing and Development 131 (2010), 5, pp. 366-369 Konstanzer Online-Publikations-System (KOPS) URN: http://nbn-resolving.de/urn:nbn:de:bsz:352-opus-130294 for maximum peak distance from start in arbitrary units in relation to temperature, As the two different proteins had to be analyzed separately due to the highly divergent signal intensities. only the shape of the graphs was compared. There is no significant difference between A762 and E988K in temperature-dependent PAR production. (c) Evaluation of the amount of PAR produced by the two enzymes. For each individual temperature we calculated the amount of PAR formed by E988K relative to A762. Probably due to a lesser degree of polymer complexity at low temperatures. signals are more focused at one spot and therefore PAR is detectable even in small amounts.
variant at amino-acid position 762 of human PARP-l population with alanine was reported to result in diminished enzymatic activity (Wang et aI., 2007) and increased predisposition to certain cancers (Li et aI., 2007; Lockett et aI., 2004) . Other groups, however, were unable to detect any influence on PARP-l activity by this polymorphism (Zaremba et aI., 2009) . In order to clarify this issue and to re-assess the question of life span related PARP-l function, we set out to determine activity parameters of recombinant PARP-1 of human and rodent origin. Using the well-established baculoviral system for protein overexpression and our previously published purification protocol (Beneke et aI., 2000) , we purified recombinant PARP-1 to near-homogeneity. All preparations tested negative for automodification by western blotting with 10H antibody. By utilizing a modified immuno-slot-blot technique, we established a sensitive method for detection and quantification of PAR. We routinely used 30 s reaction time at 30'C with 2.5 nM PARP-l in 30 J.LI of reaction buffer (200 J.LM NAO+, 25 mg/ml GGAATTCC activator oligonucleotide, 1 mM OTT, 100 mM Tris-HCI pH 7.8, 10 mM MgCIz) if not indicated otherwise. These conditions had proven most suitable for analyses with wild-type (wt) and EGFPfused PARP-l (data not shown). Briefly, reaction mix was preincubated for 2 min at 30 cc and assay was started by addition of 1/10 volume of PARP-1 or NAO+, respectively. Reaction was stopped by adding an equal volume of 20% trichloroacetic acid (TCA). Slot-blotting in a 72-well manifold was performed as follows: 3 sheets of What man paper and PBS-soaked Hybond-N+ membrane (GE Healthcare) were assembled according to manufacturer's instructions. Each solution was applied to slots in a 50 J.Ll volume. Before application of samples, PBS was aspirated through the slots. Five % of each reaction, diluted with 10% TCA, was transferred to the membrane, respectively. After transfer, all wells were washed once with 10% TCA and once with 70% ethanol. Thereafter, membranes were dried for 1 h at 90 QC and blocked overnight at 4 cC in TNT (0.05% Tween 20, 150 mM NaCl, 10 mM Tris-HCI pH 8.0)/5% dry milk. One-hour incubation with the first antibody (anti-PAR mouse monoclonal 10H) in TNT/5% dry milk was followed by 3 x 10 min washes in TNT, 1-h incubation with the secondary antibody (goat-antimouse HRP, dako cytomation) in TNT/5% dry milk, and three TNT (a) [NAD+] rat PARP-1 PARP-1/A762 PARP-1N762
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t::::::::::::-. washes as above, For ECL reaction, Advanced ECL (GE Healthcare) was used and visualized by Fuji-LAS1000. Evaluation of signal intensities was done with Aida3.5 or ImageJ (MacBiophotonics) software. Production of graphs and statistical analysis was performed using PrismS and Instat3 software (GraphPad). In order to determine optimal conditions for PARP-l activity, we first tested in triplicates polymer production at different temperatures by standard western blotting (including stacking gel) with antibody 1 OH. To detect suitable amounts of PAR, we used 100 ng (17.7 nM) PARP-1 (A762 variant) and 1 min incubation time. stopping the reaction by addition of the PARP inhibitor PJ34 (10 f.lM; Alexis Biochemicals). As a presumed negative control, a PARP-l mutant with substitution of glutamate at amino-acid position 988 to lysine (E9881<) was chosen, which has been described as a mono-ADP-ribose transferase lacking polymerizing Table t Enzymatic parameters of different poly(ADP-ribose) polymerase-1 versions. activity (RolIi et aI., 1997), thus catalyzing covalent protein modification with a single ADP-ribose unit, which is not detected by 10H antibody, Surprisingly, we did detect low level of PAR upon activation of the E9881< mutant with a similar temperature dependency as the A762 variant and an optimum between 30 and 37 DC ( Fig. la and b) . This polymerizing function apparently had gone unnoticed so far when using radioactively labeled NAD+, as we calculated that E9881< activity is only 1-3% of A762 variant, depending on reaction temperature (Fig. 1 c) . To exclude contamination with insect PARP during the purification process, we infected S19 cells with either a PARP-l cDNA-carrying virus or an unrelated wt virus and performed purification side by side. The dialyzed solution from control preparation did not contain any detectable PARP activity (Supplement Fig. 1 ). Therefore. the E9881< mutant is the source not only of the reported mono-ADP-ribose transferase activity but also the polymerizing activity, which has to be taken into account if this mutant is used in experiments designed to dissect enzymatic functions. In order to check if the correlation between life span and PARP activity in permeabilized PBMC is reflected in the recombinant PARP-l of the respective species, we used rat and human PARP-1, and in the latter case the two different alleles A762 and V762. Recently, recombinant V762 was shown to produce twice as much polymer compared to A762, which was reflected in a slightly higher affinity (1.2x) to NAO+ (lower KM) (Wang et aI., 2007) . Those authors had used a commercially available kit to determine substrate affinity, but maximum velocity (Vmax) had not been reported.
We tested recombinant rat and human PARP-1 as described above, and varied NAO+ concentrations (Fig. 2) . Transferring to the same blot a known amount of purified PAR (Supplement Fig. 2 ), we were able to calculate Michaelis-Menten constant KM as well as maximum velocity V max . We could show that rat PARP-1 has a nearly 2-fold higher KM compared to human enzymes, whereas KM of A762 and V762 is almost identical (l.l-fold difference), in line with previous results (Table 1) . In contrast, V762 shows a 2.1-fold higher velocity compared to A762, with the latter one being slightly more active than rat PARP-1 (1.3-fold). The turnover number k cat (S1) for rat, A762 and V762 mirrors the differences in V max values (2.1, 2.9, and 6.2, respectively), and the calculated enzyme efficiency kcat/KM (S-1 M·· 1 ) for rat and V762 PARP-1 (3.58 x 10 4 and 18.39 x 10 4 , respectively) perfectly reflects the 5-fold activity difference detected in permeabilized PBMC (Grube and Blirkle, 1992) .
In summary, we were able to confirm PARP activity data from PBMC with purified recombinant proteins. Thus, activity difference between the common V762 version of human PARP-1 and rat PARP-1 can easily be explained by different enzymatic characteristics ofPARP-l itself and no differential interaction ofPARP-1 with other proteins needs to be postulated. This also implies that the cellular background (Iymphocytes) is not accounting for the activity difference published before. Additionally, we could show for the first time that there is a quality difference between the activities of different PARP-l proteins, either divergence in substrate affinity (rat vs. human) or in maximum velocity (human alleles). We also showed that velocity and not KM is the main parameter differing in the A762 variant compared to the more frequent V762. Unexpectedly, we also identified the PARP-l E988[( mutant as a low-level poly(AOP-ribose) polymerase, in contrast to previous reports. As is evident from the signal distribution in western blots (Fig. la) as well as silver-staining of size-separated purified PAR (Suppl. Fig. 3) , complexity of the polymer seems to be identical between A762 allele and E988K mutant. This has to be taken into account in experiments either aiming at dissection of the three different steps in PARP-l activity, or in attempts of replacing polymerizing function of PARP-l by mono-transferase activity.
